Berylson Capital Partners’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
Other funds holding CLOV
GCP
SIG
AI
PA
LCM
Berylson Capital Partners's CLOV Position: Q1 2021 in Review
Berylson Capital Partners sold out of Clover Health Investments (CLOV) in Q1 2021, closing a stake of 1,196,200 shares — an estimated $20.1M sold.
Berylson Capital Partners first reported a position in CLOV in Q4 2020 and held it in 1 quarter. The position peaked at $20.1M in Q4 2020. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2021.
- Berylson Capital Partners reported no remaining Clover Health Investments position as of Q1 2021 after selling out during the quarter.
- Berylson Capital Partners sold 1,196,200 Clover Health Investments shares in Q1 2021, an estimated $20.1M.
- Berylson Capital Partners first reported a position in Clover Health Investments in Q4 2020 and held it in 1 quarter.
- Berylson Capital Partners's Clover Health Investments position peaked at $20.1M in Q4 2020.
- 137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2021.
Based on Berylson Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.